Status:
NOT_YET_RECRUITING
Effects of Repetitive Transcranial Magnetic Stimulations in Patients With Amphetamine Use Disorders
Lead Sponsor:
TsaoTun Psychiatric Center, Department of Health, Taiwan
Conditions:
Amphetamine Use Disorders
Amphetamine Use Disorder
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Amphetamine Use Disorder (AUD) is a major public health issue in Taiwan, where it is the most commonly abused illegal drug. There are currently no effective approved medications to treat it, which mak...
Detailed Description
Amphetamine Use Disorder (AUD) is a serious and growing public health concern, especially in Taiwan, where amphetamines are the most commonly misused illegal drugs. Globally, amphetamines also rank am...
Eligibility Criteria
Inclusion
- Age ≥20 years.
- Meeting DSM-5 criteria for substance use disorder made by a specialist in addiction psychiatry.
- Fluency in Chinese.
- Willingness and ability to comply with study requirements.
- Good physical health determined by complete physical examination, and laboratory tests.
- Patient or a reliable caregiver can be expected to ensure acceptable compliance and visit attendance for the duration of the study.
- Trained psychiatrists will assess eligible patients using the structured clinical interview for the Mini-International Neuropsychiatric Interview (MINI) (Sheehan et al., 1998) to determine the presence of any psychotic disorder.
Exclusion
- Evidence of an uncontrolled and/or clinically significant medical condition, e.g., cardiac, hepatic and renal failure that would compromise patient safety or preclude study participation.
- Premorbid mental retardation.
- Other major Axis-I Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) diagnoses other than substance use disorder.
- Pregnancy or nursing.
- History of seizures or epilepsy.
- History of neurological diseases or traumatic brain injury.
- Suicidal attempts or risks during screening or study period.
- Presence of prosthesis devices, e.g. pace-makers, cochlear prosthesis, neuro- stimulators, magnetic cochlear prosthesis, intraocular metallic fragments.
Key Trial Info
Start Date :
May 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06960265
Start Date
May 15 2025
End Date
December 31 2025
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TsaoTun Psychiatric Center
Nantou City, Taiwan